enVVeno Medical Corporation (NVNO) News
Follow enVVeno Medical Corporation (NVNO) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 7 public stories across 4 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
NVNO - enVVeno Medical CEO Rob Berman Goes Direct to Investors with New "WTF" Video Series
NVNO - enVVeno Medical CEO Rob Berman Goes Direct to Investors with New "WTF" Video Series
NEWS | Sep 16, 2026, 12:50 PM UTC
L
JTC Team Releases Virtual Investor "Why Now" On-Demand Conference Featuring Nine Public Company CEOs
JTC Team Releases Virtual Investor "Why Now" On-Demand Conference Featuring Nine Public Company CEOs
EQUITY | Aug 27, 2026, 01:01 PM UTC
L
enVVeno Medical Participates in the Virtual Investor 'Why Now' On-Demand Conference
enVVeno Medical Participates in the Virtual Investor 'Why Now' On-Demand Conference
EQUITY | Aug 27, 2026, 01:01 PM UTC
L
NVNO participates in Virtual Investor 'Why Now' on-demand conference
enVVeno Medical will participate in the Virtual Investor 'Why Now' on-demand conference.
EQUITY | Aug 27, 2026, 01:01 PM UTC
M
NVNO Reports Economic Dominance
NVNO's valve therapy economically dominates standard care
EQUITY | Aug 04, 2026, 12:46 PM UTC
L
NVNO Envveno Medical Corp: company enters the second half of 2026 with tailwinds from an FDA ide approval - Tavve pivotal study expected to
NVNO Envveno Medical Corp: company enters the second half of 2026 with tailwinds from an FDA ide approval - Tavve pivotal study expected to begin enrolling patients during the second half of this year
REGULATION | Jul 31, 2026, 12:35 PM UTC
L
NVNO - enVVeno Medical Reports Second Quarter 2026 Financial Results and Advances Towards FDA Pivotal Trial for First-in-Class Non-Surgical
NVNO - enVVeno Medical Reports Second Quarter 2026 Financial Results and Advances Towards FDA Pivotal Trial for First-in-Class Non-Surgical Replacement Venous Valve
EARNINGS | Jul 31, 2026, 12:30 PM UTC